Predicting Wilson’s Disease Progression using Machine Learning with Real-World Electronic Health Records

Caihua Liang, Scott P. Kelly, Rongjun Shen, Ling Li, Kasia Lobello, Steven Arkin, Kui Huang, Xiaofeng Zhou
doi: https://doi.org/10.1101/2023.07.28.23293309

Article Information

doi 
https://doi.org/10.1101/2023.07.28.23293309
History 
  • August 4, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Caihua Liang, MD, PhD1,*,
  2. Scott P. Kelly, PhD, MS1,
  3. Rongjun Shen, MS1,
  4. Ling Li, MS1,
  5. Kasia Lobello, MD2,
  6. Steven Arkin, MD3,
  7. Kui Huang, PhD, MPH1 and
  8. Xiaofeng Zhou, PhD, MS1
  1. 1Pfizer, Global Medical Epidemiology, New York, NY
  2. 2Pfizer, Global Product Development, Collegeville, PA
  3. 3Pfizer, Worldwide Research and Development, Cambridge, MA
  1. ↵*Corresponding author:
    Caihua Liang, MD, PhD, Global Medical Epidemiology, Worldwide Medical & Safety, Pfizer, Inc., 235 East 42nd Street, New York, NY 10017, Email: Caihua.Liang{at}pfizer.com
Back to top
Posted August 04, 2023.
Download PDF
Email
Predicting Wilson’s Disease Progression using Machine Learning with Real-World Electronic Health Records
Caihua Liang, Scott P. Kelly, Rongjun Shen, Ling Li, Kasia Lobello, Steven Arkin, Kui Huang, Xiaofeng Zhou
medRxiv 2023.07.28.23293309; doi: https://doi.org/10.1101/2023.07.28.23293309
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area